Foghorn Therapeutics Ratios (2020-2025) | FHTX

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin 5,419.38%7,947.98%-10,441.90%-8,406.37%-8,257.34%-8,514.70%-65,268.29%-3,998.32%-686.58%-608.31%-388.44%-690.39%-563.72%-509.82%-77.85%-383.43%-495.37%-333.61%-244.90%-682.88%-339.73%-248.62%-202.00%
EBIT Margin 5,319.38%7,847.98%-10,329.05%-8,278.49%-8,087.41%-8,337.28%-64,051.22%-3,938.57%-709.29%-650.07%-425.97%-762.09%-627.56%-572.42%-97.73%-441.29%-558.30%-386.64%-305.48%-840.51%-384.96%-279.17%-226.92%
EBITDA Margin 5,407.75%7,940.91%-10,260.89%-8,272.91%-8,032.52%-8,289.25%-63,617.07%-4,086.96%-716.79%-652.74%-413.69%-669.41%-553.25%-523.95%-77.35%-399.36%-488.85%-331.30%-235.96%-690.76%-318.46%-238.11%-193.56%
Operating Margin 5,319.38%7,847.98%-10,329.05%-8,278.49%-8,087.41%-8,337.28%-64,051.22%-3,938.57%-709.29%-650.07%-425.97%-762.09%-627.56%-572.42%-97.73%-441.29%-558.30%-386.64%-305.48%-840.51%-384.96%-279.17%-226.92%
Net Margin 5,419.38%7,947.98%-10,441.90%-8,406.37%-8,257.34%-8,514.70%-65,268.29%-3,998.32%-686.58%-608.31%-388.44%-690.39%-574.27%-526.65%-82.07%-417.85%-495.37%-333.61%-244.90%-682.88%-339.73%-248.62%-202.00%
FCF Margin 4,741.47%7,269.19%-1,507.82%-7,228.69%-8,720.63%-7,058.06%-50,565.85%1,655.26%6,920.59%-654.25%-306.24%-697.73%-599.28%-583.03%-156.15%-478.04%-583.09%-370.99%-272.98%-875.28%-403.16%-278.18%-231.33%
Efficiency
Assets Average 199.01M242.74M219.21M197.30M352.92M504.04M472.60M445.42M419.41M388.88M356.23M326.50M299.67M270.46M291.79M318.48M296.18M271.34M242.46M215.60M
Equity Average -108.81M-124.87M6.43M135.68M114.68M92.59M88.93M84.64M60.02M35.98M12.22M-12.24M-36.97M-53.37M-67.29M-87.34M-55.90M-21.30M-36.91M-53.59M-69.16M-83.16M
Invested Capital -101.20M-116.41M-127.33M165.84M144.90M124.02M100.90M96.87M72.40M47.63M24.32M0.11M-24.59M-49.35M-57.39M-77.19M-97.49M-14.32M-28.29M-45.53M-61.65M-76.66M-89.66M
Asset Utilization Ratio 0.000.000.000.000.000.010.020.040.050.050.060.100.110.130.120.080.080.090.100.11
Leverage & Solvency
Interest Coverage Ratio -53.19-78.48-91.53-64.73-47.59-46.99-52.63-65.92
Debt to Equity -0.110.13
Debt Ratio 0.100.08
Equity Ratio -0.940.570.540.500.440.190.150.100.060.00-0.07-0.15-0.18-0.27-0.38-0.04-0.09-0.16-0.24-0.34-0.44
Times Interest Earned -53.19-78.48-91.53-64.73-47.59-46.99-52.63-65.92
Valuation
Enterprise Value -3.44M-36.56M-75.16M633.15M418.80M267.98M456.69M747.15M417.21M502.76M269.62M214.48M208.54M236.74M139.00M191.96M206.36M105.92M457.43M206.95M141.96M188.16M185.85M
Market Capitalization 725.94M485.24M393.15M514.53M848.28M630.86M563.96M357.25M266.70M259.19M294.45M209.31M272.30M285.62M244.87M515.11M262.40M202.98M261.98M276.43M
Return Ratios
Return on Sales -152.79%-87.60%-111.12%-77.82%-21.39%-11.95%-6.89%-5.66%-5.45%-5.28%-3.17%-2.88%-2.74%-2.46%-3.58%-3.83%-3.48%-3.21%-3.06%
Return on Capital Employed -0.38%-0.34%-0.42%-0.52%-0.33%-0.23%-0.26%-0.29%-0.32%-0.37%-0.42%-0.42%-0.45%-0.47%-0.40%-0.40%-0.45%-0.49%-0.56%-0.66%
Return on Assets -0.35%-0.33%-0.40%-0.48%-0.29%-0.21%-0.23%-0.24%-0.26%-0.29%-0.32%-0.32%-0.33%-0.34%-0.30%-0.29%-0.29%-0.30%-0.32%-0.35%
Return on Equity -10.81%-0.58%-0.76%-1.03%-1.15%-1.25%-1.82%-3.02%-8.91%9.19%3.10%1.93%1.46%1.06%1.55%4.28%2.35%1.53%1.12%0.90%